Fábrica de Produtos Alimentícios Vigor SA is being offered to about half a dozen peers including Groupe Lactalis SA and Danone SA, as the Brazilian dairy producer’s owners raise cash to pay the world’s largest leniency fine and other debts, two people with knowledge of the process said on Tuesday.
The process to sell Vigor, which the investment banking units of Banco Santander Brasil SA and Banco Bradesco SA are advising, is in an initial stage, said the people, who declined to elaborate on the bidding process.
Apart from both French dairy producers, other companies invited to analyze Vigor’s business include Mexico’s Grupo Lala SAB de CV and Switzerland’s Emmi AG, the people said. So far, no price or a deadline for offers was decided, and there is no certainty a deal can be reached, the people said.
The media office of Danone declined to comment. J&F, Lala, Lactalis, Emmi and the banks did not immediately comment on the matter. The people asked for anonymity to speak freely about the process.
The plan comes two weeks after J&F Investimentos SA, the family holding company that controls Vigor, agreed to pay a record-setting 10.3 billion-real ($3.1 billion) leniency fine. J&F also needs cash to repay about 14 billion reais in loans coming due within the next 12 months, Reuters reported on June 7.
Members of J&F’s Batista family entered plea deals in which admitted bribing politicians to win advantages for their meatpacking, financial, pulp and apparel empire.
Foreign interest on Vigor, a relevant player in Brazil’s dairy market, has lingered for years. J&F and other companies discussed potential mergers and acquisitions for Vigor, but those talks always floundered because of price issues, sources told Reuters in recent months. ($1 = 3.3120 reais)
By Tatiana Bautzer
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.